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Summary
AIMS: The purpose of the study was to describe the type,
prevalence, severity and preventability of adverse events
(AEs) that affected hospitalised medical patients. We used
the previously developed and validated Global Trigger
Tool from the Institute for Healthcare Improvement.
METHODS: Using an adapted version of the Global Trig-
ger Tool, we conducted a retrospective chart review of
adult patients hospitalised in five medical wards at a uni-
versity hospital in Switzerland. We reviewed a random
sample of 20 patients’ charts for a total study period of
12 months (September 2016 to August 2017). Two trained
nurses searched independently for triggers and possible
AEs. All AEs were further validated by a senior physician.
The number of triggers and AEs detected, as well as the
severity and preventability of each, was assessed and
analysed using descriptive statistics.
RESULTS: From a sample of 240 patient charts, we iden-
tified 1371 triggers and 336 AEs in 144 (60%) inpatients.
This translates to an AE rate of 95.7 AEs per 1000 patient
days. Most AEs (86.1%) caused temporary harm to the
patient and required an intervention and/or prolonged hos-
pitalisation. The estimated preventability of the in-hospital
AEs was 29%. Healthcare-associated infections (25.8%)
and neurological reactions (22.9%) were the most fre-
quent AE types.
CONCLUSION: We found that about two thirds of patients
suffered from AEs with harm during hospitalisation. It is
common knowledge that AEs occur in hospitals and that
they have potentially harmful consequences for patients,
as well as a strong economic impact. However, to ad-
equately prioritise patient safety interventions, it is es-
sential to explore the nature, prevalence, severity and
preventability of AEs. This is not only beneficial for the pa-
tients, but also cost effective in terms of shorter hospital
stays.
Keywords: trigger tool, adverse events, patient safety,
patient harm, descriptive study, hospitals
Introduction
In-hospital adverse events (AEs) are a global health issue
[1]. Many medical ward patients are elderly persons with
multiple long-term conditions, making them particularly
vulnerable to AEs [2]. Therefore, especially for older pa-
tients, monitoring AEs and their consequences is a crucial
step towards implementing interventions to improve pa-
tient safety in clinical practice [3].
An AE is defined as an unintended physical injury caused
by medical care – rather than by the patient's underlying
disease – that requires additional monitoring, treatment or
hospitalisation [4]. By definition, then, AEs are associat-
ed with harm. Medical errors and other mistakes in the
process of care have the potential to be harmful; however,
as most errors cause no injury to the patient, they are not
classed as AEs [5]. Where injuries do occur, consequences
may include prolonged hospital stay, disability, increased
pain or even death [2, 6].
ABBREVIATIONS:
AE(s) adverse event(s)
CI confidence interval
GTT Global Trigger Tool
EHR electronic health record
IHI Institute of Healthcare Improvement
INR international normalised ratio
IQR interquartile range
MASD moisture-associated skin damage
NCC MERP
National Coordinating Council for Medication Error Re-
porting and Prevention Index
PPV positive predictive value
PSI patient safety indicators
SD standard deviation
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AEs are common with a wide range of reported incidence.
A systematic review showed that between 3.2% and 16.6%
of all hospitalised patients were affected by at least one
AE [6]. In a more recent US study, 21% of medical inpa-
tients suffered from at least one AE [7]. From an econom-
ic perspective, the most obvious impacts of AEs include
extra hospitalisation days and additional treatment [2, 6].
A Danish study found a higher mean cost of EUR 9505
per patient exposed to an AE and hospital stay [8]. The
most frequently named AE types were adverse drug events,
hospital-acquired infections, operative/procedural injuries,
poor glycaemic control, venous thromboembolism and
pressure ulcers [7].
Depending on the standard of care available, several types
of AE are considered preventable [9]. A 2016 multi-coun-
try systematic review of nine general hospital studies indi-
cated that incidences of these AE types range from 14 to
71% [10]. In a Swiss hospital, one study reported an over-
all AE incidence of 14.1%, 42% of which were judged pre-
ventable [11]. It is estimated that AEs of all kinds lead to
700–1700 deaths per year in Swiss hospitals [12].
Several approaches to AE measurement exist: (1) clinical
surveillance of specific types of AEs (e.g., patient falls,
surgical site infections) [13]; (2) (voluntary) incident re-
porting, which involves front-line personnel identifying
and reporting risks and near misses (errors detected before
they reach the patient) [5]; and (3) administrative data,
such as patient safety indicators (PSIs) [14], which provide
information on potential in-hospital complications and
AEs.
Unfortunately, all of these approaches miss substantial
numbers of AEs. Where statistics depend on voluntary re-
porting by care providers, several studies have noted that
both serious AEs [15] and PSIs [16, 17] are widely under-
reported. As a result, the most common method of assess-
ing AEs [18] is retrospective chart review: the review of
patient charts by trained medical reviewers to identify evi-
dence of patient care-related injuries.
One promising chart review method is the Global Trigger
Tool (GTT). Developed by the Institute for Healthcare Im-
provement (IHI) in the US in 2003 [4], the GTT consists
of a systematic two-stage review of closed patient charts,
offering an efficient and reliable method of measuring AEs
over time. In a US adult care setting, the GTT showed a
sensitivity of 95%, with 100% specificity [17]. The GTT
has been used extensively across numerous countries and
settings, commonly in a form modified to match the spe-
cific setting’s needs and patient characteristics (e.g., the re-
view process may be changed, modules omitted and trig-
gers adapted) [3, 10].
Improving patient safety in hospitals demands effective
and reliable monitoring of AEs. To our knowledge, though,
only one study has measured in-hospital AEs via chart re-
view methodology in a community hospital in Switzerland
[11]. As GTT methodology had not yet been used in Swiss
hospitals, we applied it to explore AEs in the Department
of General Internal Medicine at a university hospital. The
purpose of this study was to determine the types, preva-
lence, severity and preventability of AEs occurring in hos-
pitalised medical patients, using the GTT as a screening
tool.
Materials and methods
Design and setting
This descriptive, retrospective chart review study was con-
ducted in the Department of General Internal Medicine at a
university hospital in Switzerland. In 2016, this department
consisted of five medical wards with roughly 4600 patient
discharges annually and an average length of stay of 7.8
days [19]. Admissions occurred mainly through the hospi-
tal's emergency unit; the recipients of its services were pre-
dominantly older persons with multiple conditions [20].
Sample
Medical inpatients were eligible if they met all the four
following criteria: (1) aged 18 or older; (2) a minimum
length of stay of 24 hours; (3) had a discharge summary;
and (4) all coding completed within 30 days of hospital
discharge. The records of readmissions were excluded and
not reviewed if they were not the index admission.
Between September 2016 and August 2017 (12 months),
once per month, using the R software package, a scientific
assistant randomly selected 30 electronic patient charts
from those of all patients hospitalised in the internal med-
icine wards of the study hospital. The selected patients’
eligibility was then checked by one reviewer. Of the 30
charts initially extracted, the first 20 that were eligible
were used for chart review each month. A total sample size
of 240 randomly selected patient charts was targeted. In
this study, no formal power analysis was performed; how-
ever, based on the AE rate of 12.3% found in a Swedish
study [21], a 95% confidence interval (CI) of 0.084–0.170
was expected with a sample size of n = 240.
Variables and measurements
All patient information originated from administrative data
or from the electronic health record (EHR) of the study
hospital.
Trigger selection and tool development.
The study focused on medical wards, but included the en-
tire period of hospitalisation, even if patients were treated
in multiple departments during the index hospitalisation.
AEs were assessed using two of the GTT’s six modules:
“care” and “medication”, as well as two triggers from the
surgical module. Of remaining three modules of the orig-
inal GTT, two (“emergency department” and “intensive
care”) were excluded because of EHR system differences;
the third (“perinatal”) was omitted because it was irrele-
vant to our study population.
Each module of the GTT focuses on specific triggers [4].
These were adapted to our local setting and translated into
German by the research team. As a guide, the members
used the German translation provided by the IHI [22]. We
adopted some of the guidance of the GTT handbook [4] as
necessary, for example, in the case of drug brand names
(e.g., Anexate®), the types of drugs used (e.g., antihist-
amine), laboratory thresholds (e.g., the international nor-
malised ratio [INR] >4). Furthermore, because of the elder-
ly and comorbid population of our study, we treated each
readmission within 30 days as an AE. In cases where the
reason for readmission might have been caused by the un-
derlying disease, we rated the preventability as low. In ad-
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dition, three triggers developed by the research team and
expert nurses from medical wards (delay in discharge, sud-
den change in cognitive function, and phlebitis / extravasa-
tion injury) were included. In total, this study used 32 trig-
gers (see appendix 1 for a full list).
Harm from adverse events
Each AE was categorised according to whether it origi-
nated prior to admission (e.g., pneumonia diagnosed with-
in 72 hours of admission was considered to be present on
admission) or during hospitalisation. The National Coor-
dinating Council for Medication Error Reporting and Pre-
vention Index (NCC MERP) harm classification A–I was
used to assess event severity [23]. In accordance with the
GTT handbook [4], only categories E–I were considered
AEs as only this group caused harm to the patients (catego-
ry E = temporary harm to the patient and required interven-
tion; F = temporary harm to the patient requiring initial or
prolonged hospitalisation; G = permanent patient harm; H
= intervention required to sustain life; I = patient’s death)
[23].
Preventability of adverse events
Reviewers with clinical knowledge and experience as-
sessed the preventability of the identified in-hospital AEs
using a four-point Likert-type scale: range 1–4 (1 = not
preventable, 2 = probably not preventable, 3 = probably
preventable, 4 = preventable). Any AEs receiving scores of
3 or 4 were considered preventable. An event was consid-
ered preventable if it was avoidable in the light of the stan-
dard care available at the time [9].
Data collection and screening procedure
Data were collected from December 2016 to October 2017
using the EHR of the study hospital. The review team con-
sisted of three healthcare professionals: (1) two primary
reviewers who were nurses with bachelors’ degrees, more
than 5 years of experience each in internal medicine and
knowledge of the EHR; and (2) one trained physician with
more than 10 years’ experience in internal medicine. The
review team remained unchanged for the total data collec-
tion period.
The review team completed a training session to enhance
their consistency and ensure a thorough understanding of
the GTT methodology. The training consisted of: (1) read-
ing the IHI handbook [4]; (2) individual training using the
five charts provided on the IHI’s website; and (3) prac-
tice by the primary reviewers on 15 patient charts, five of
which were discussed with the physician. After this train-
ing, the EHR data review worksheets were created and
adapted.
The screening process consisted of one primary and one
secondary review (fig. 1).
Primary review
The two nurses reviewed each EHR independently for a
maximum of 20 minutes. They reviewed the chart sections
in the following order: discharge summary, laboratory re-
sults, medication administration record, vital signs, nursing
care plan, nursing notes, doctor notes, operative record and
organisational notes for discharge. If a trigger was identi-
fied, the reviewer determined whether an AE had occurred
by further checking relevant parts of the record. The pri-
mary reviewers assessed the frequency, type, severity and
preventability of each AE. After completing their separate
reviews, the two primary reviewers discussed their find-
ings and reached consensus regarding the suspected AEs,
which they then recorded on a consensus worksheet. Data
entry was cross-checked for quality assurance in 4% (n =
10) of patient charts.
Secondary review
The physician reviewed the consensus worksheet to reach
a final decision on the frequency, type, severity and pre-
ventability of the possible in-hospital AEs. If there was any
disagreement between the reviewers, this was discussed
until consensus was reached. In addition, the physician
provided answers to any questions from the primary re-
viewers that had arisen during the screening process.
Statistical analyses
All statistical analyses were performed using the R statisti-
cal software package, version 3.4.4 on Windows [24]. De-
scriptive analysis of the patients focussed on seven vari-
ables: gender, age, main diagnosis, length of hospital stay,
surgery during hospitalisation, readmission within 30 days
after chart review and whether the patient was deceased.
We calculated frequencies and percentages with 95% CIs
both for the type, level of harm and preventability of the
AEs and for the triggers. We also calculated the prevalence
and incidence of AEs per 1000 patient days.
For each trigger noted in the EHR, a positive predictive
value (PPV), indicating the probability that it identified an
AE, was calculated. Each trigger that directly indicated an
AE was counted, with allowances for cases where several
triggers were associated with a single AE and where one
trigger indicated several AEs. The PPV was calculated as
the number of AEs associated with each trigger divided
by the number of triggers identified in all studied charts.
To determine the quality of the screening process, we as-
sessed interrater reliability both between the two primary
reviewers and between the reviewers and the physician via
Cohen’s kappa (κ) coefficient. The agreement between re-
viewers was defined as follows: (1) agreement on the pres-
ence or absence of AEs by calculating the Cohen kappa;
and (2) agreement on the number of AEs by calculating
the weighted Cohen kappa, where high disagreement cor-
responds to high weights [25]. A kappa coefficient <0.2 is
considered poor, 0.21–0.60 fair to moderate, >0.60 accept-
able, and ≥0.75 very good [26].
Ethical considerations
The regional Ethics Committee of Bern
(KEK-2016-01720) approved this study based on the gen-
eral consent of patients in the participating hospital.
Results
Two-stage reviews were performed on 240 patient charts
(male: 126; mean age 69.8 years, standard deviation [SD]
16.4; range 19–104 years). The most frequent diagnoses
were circulatory diseases (17.1%) and neoplasms (15.0%).
Ten patients (4.2%) died during the index hospitalisation.
The mean length of stay in hospital was 14.6 days (SD
11.6). Patients undergoing surgery (21.2%) during their ad-
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mission had longer stays, with a mean of 25.3 days (SD
14.7). For further details, see table 1.
Triggers
The chart reviews identified 1701 triggers. Of these, 330
(19.4%) were present on admission, with the remaining
1371 (80.6%) occurring during hospitalisation. The medi-
an numbers of triggers per patient was five (IQR 3–8). The
most prevalent triggers during hospitalisation were “anti-
emetic administration”, “other” and “any procedure com-
plication” (table 2).
Adverse events
We identified 1136 events, of which 614 (54.0%) were
classified as AEs with harm to patients (NCC MERP harm
classifications E–I). Of these 614 AEs, 278 (45.3%) were
present on admission and 336 (54.7%) occurred during
hospitalisation (fig. 2). Detailed results of AEs present on
Figure 1: Screening procedure for the identification of adverse events. Two nurses review each electronic health record independently within
a maximum time limit of 20 minutes. They compare and discuss their findings and reach consensus. The physician afterwards verifies the find-
ings of the in-hospital AEs (harm E–I).AE = adverse event; IRR = interrater reliability; POA = present on admissionThe National Coordinating
Council for Medication Error Reporting and Prevention Index (NCC MERP) categories: A–D = no harm to patients, E–I = harm to patients
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admission are provided in appendix 2. The 336 AEs de-
tected during hospitalisation represented an AE rate of 95.7
AEs per 1000 patient days. These 336 were present in 144
(60.0%) separate patient records: 63 (26.3%) patients suf-
fered from one AE, 33 (13.8%) from two and 48 (20.0%)
from three or more. The median number of AEs per patient
record was 1.0 (interquartile range [IQR] 0–2; range 0–8)
per patient. Healthcare-associated infections such as pneu-
monia, and urinary tract and fungal infections were the
most frequent AE type, representing 62 AEs (25.8%), fol-
lowed by neurological reactions such as delirium (55 AEs,
22.9%), readmissions (36 AEs, 15%) and skin/tissue dam-
age (24 AEs, 10%). Readmissions were most commonly
caused by infections, bleedings, pain and falls.
The most common categories of severity were E (146 AEs,
43.5%) and F (143 AEs, 42.6%). Both indicate temporary
Table 1: Characteristics of the patients included in the GTT screening process.
Variables n = 240
Age, mean (SD) in years 69.8 (16.4)
Men, n (%) 126 (52.5)
Main diagnosis*, n (%) Diseases of the circulatory system (IX) 41 (17.1)
Neoplasms (II) 36 (15.0)
Injury, poisoning and certain other consequences of external causes (XIX) 25 (10.4)
Infectious, parasitic diseases (I) 25 (10.4)
Diseases of the nervous system (VI) 18 (7.5)
Diseases of the respiratory system (X) 18 (7.5)
Length of hospital stay, mean (SD) in days 14.6 (11.6)
Surgery†, n (%) 51 (21.2)
Deceased, n (%) 10 (4.2)
Readmission after chart review (within 30 days), n (%) 36 (15.0)
GTT = Global Trigger Tool; SD = standard deviation * Based on ICD-10-GM [27]; † catheter-based interventions are included.
Table 2: Prevalence of triggers during hospitalisation.
Module Trigger (n = 32) n Prevalence
% (95% CI)
n = 240
PPV (%)*
Care Transfusion / use of blood products 45 18.8 (14.0–24.3) 53.5
CPR team / MET activation or severe health deterioration 36 15.0 (10.7–20.2) 77.8
Acute dialysis 1 0.4 (0.0–2.3) 0.0
Positive cultures 44 18.3 (13.6–23.8) 68.2
X-Ray for emboli or DVT 5 2.1 (0.7–4.8) 40.0
Decrease in haemoglobin of ≥25% 21 8.8 (5.5–13.1) 52.4
Patient fall 22 9.2 (5.8–13.5) 27.3
Pressure ulcers 47 19.6 (14.8–25.2) 42.6
Readmission within 30 days 36 15.0 (10.7–20.2) 100.0
Restraint use 48 20 (15.1–25.6) 64.6
Infections 83 34.6 (28.6–41.0) 72.3
Stroke 6 2.5 (0.9–5.4) 100.0
Transfer to higher level of care 53 22.1 (17.0–27.9) 47.2
Any procedure complication 179 74.6 (68.6–80.0) 57.0
Other 157 65.4 (59.0–71.4) 33.8
Medication C. difficile-positive stool 4 1.7 (0.5–4.2) 100.0
PTT >100 seconds 5 2.1 (0.7–4.8) 40.0
INR >4 4 1.7 (0.5–4.2) 50.0
Glucose ≤3mmol or ≥15 mmol 32 13.3 (9.3–18.3) 6.3
Serum creatinine 2× over baseline 8 3.3 (1.4–6.5) 37.5
Vitamin K administration 39 16.2 (11.8–21.5) 20.5
Antihistamine administration 27 11.2 (7.5–15.9) 37.0
Flumazenil administration 2 0.8 (0.1–3.0) 0.0
Naloxone administration 2 0.8 (0.1–3.0) 0.0
Anti-emetic administration 132 55.0 (48.5–61.4) 18.9
Oversedation hypotension 89 37.1 (31.0–43.5) 13.5
Abrupt medication stop 9 3.8 (1.7–7.0) 44.4
Surgical Any operative complication 36 15.0 (10.7–20.2) 97.2
Troponin levels >1.5 ng/l or µg/ml 20 8.3 (5.2–12.6) 25.0
Self-developed
triggers
Delay in discharge 39 16.2 (11.8–21.5) 33.3
Phlebitis or extravasation injury 82 34.2 (28.2–40.5) 8.5
Sudden change in cognitive functions 58 24.2 (18.9–30.1) 86.2
Total 1371 – –
CI = confidence interval; CPR = cardio pulmonary resuscitation; DVT = deep vein thrombosis ; INR = international normalised ratio; MET = medical emergency team; PPV =
positive predictive value; PTT = partial thromboplastin time * PPV shows the probability that a trigger can identify an AE.
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harm to patients and they are distinguished by the time
necessary to correct the AE: category E events require
brief interventions; category F events require extensions of
the affected patients’ hospital stays. Twenty-eight (11.6%)
patients suffered from life-threating or fatal AEs, such as
intraoperative trauma to the lungs, gastrointestinal bleed-
ing or septic shock. Of the 336 AEs identified, 98 (29%)
were judged preventable. The most preventable AEs were
urinary retention (100%, n = 1), pressure ulcers (88.9%, n
= 16), falls (50%, n = 6), surgical complications (46.2%, n
= 13) and “others” (42.4%, n = 33). In the category “oth-
ers”, a wide variety of AEs such as heart failure or res-
piratory distress (e.g., in the context of fluid substitution),
medication errors, delayed treatment or blocked and dis-
located tubes/catheters are summarised. Table 3 shows the
most prevalent AE types, with their prevalence, severity
and preventability (see appendices 3 and 4 for more de-
tailed results).
Figure 2: Overview of the severity and point of origin of the identi-
fied events.Hosp. acq. = hospital-acquired; POA = present on ad-
missionThe National Coordinating Council for Medication Error Re-
porting and Prevention Index (NCC MERP) categories: A–D = no
harm to patients, E–I = harm to patients
Positive predictive value
Positive predictive values to identify a true AE were cal-
culated for all triggers occurring during hospitalisation.
These ranged from 0% for three triggers (acute dialysis,
naloxone or flumazenil) to 100% for three triggers (read-
mission within 30 days, stroke, Clostridium difficile-pos-
itive stool). The median PPV was 41.3 (IQR 23.9–65.5)
(see table 2 for further details).
Interrater reliability
The Cohen’s kappa (κ) for interrater reliability between the
primary reviewers regarding the presence of an AE was
0.98, with a percentage agreement of 99.6%. Regarding
agreement on the number of AEs between the primary re-
viewers, κweighted was 0.96, with a percentage agreement of
80.8%; between the primary reviewers and the physician,
κweighted was = 0.98, with a percentage agreement of 87%.
Discussion
We identified 1701 triggers and 614 AEs, of which 336
occurred during hospitalisation–indicating an in-hospital
AE rate of 95.7 AEs per 1000 patient days. Our study
showed that the GTT is a comprehensive method for iden-
tifying a broad spectrum of AEs in a typical internal med-
icine population of mostly elderly inpatients. In addition,
it distinguished clearly between AEs already apparent at
admission and those that arose during hospitalisation. As
suggested by a recent systematic review concerning trigger
tools, detailed results were reported [28].
Triggers
PPVs are often used to assess the efficiency of triggers
[3]. In this study, those determined for individual triggers
ranged from 0% to 100%. Similar results were reported by
one US [29] and one Italian study [30]. Studies have shown
considerable variation regarding triggers’ PPVs regardless
of their settings or patient populations [3].
In our study, four triggers – “stroke”, “readmission within
30 days”, “C. difficile-positive stool” and “any operative
complication” – had the highest PPVs. The first three of
these were reliable predictors that always led to an AE in
every case they appeared. The trigger “any operative com-
plication” usually indicated complications during surgery
that led to harm to patients, giving a high PPV. One previ-
ous study yielded a PPV of 2.9% for ”readmissions within
Table 3: Type, prevalence, severity and preventability of the most prevalent adverse events during hospitalisation for categories E to I only.
Type of AE Prevalence of AEs
n = 240
Severity of AEs according to NCC MERP (E–I)*, n (%) Preventability†
Preventable %
n % (CI) E F G H I
Infections 62 25.8 (20.4–31.9) 26 (41.9) 28 (45.2) 2 (3.2) 5 (8.1) 1 (1.6) 24.2
Neurological reaction 55 22.9 (17.8–28.8) 14 (25.5) 34 (61.8) 2 (3.6) 5 (9.1) 0 (0.0) 21.8
Readmission 36 15.0 (10.7–20.2) 0 (0.0) 34 (94.4) 0 (0.0) 2 (5.6) 0 (0.0) 25.0
Skin/tissue damage 24 10.0 (6.5–14.5) 24 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 33.3
Bleeding 21 8.8 (5.5–13.1) 13 (61.9) 5 (23.8) 1 (4.8) 2 (9.5) 0 (0.0) 19.0
Pressure ulcers 18 7.5 (4.5–11.6) 18 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 88.9
Surgical complications 13 5.4 (2.9–9.1) 5 (38.5) 2 (15.4) 1 (7.7) 5 (38.5) 0 (0.0) 46.2
Abnormal blood values 12 5.0 (2.6–8.6) 5 (41.7) 6 (50.0) 0 (0.0) 1 (8.3) 0 (0.0) 25.0
Diarrhoea 10 4.2 (2.0–7.5) 6 (60.0) 4 (40.0) 0 (0.0) 0 (0.0) 0 (0.0) 0.0
Others 33 13.8 (9.7–18.8) 7 (21.2) 16 (48.5) 1 (3.0) 4 (12.1) 5 (15.2) 42.4
AE = adverse event; CI = confidence interval; * NCC MERP = The National Coordinating Council for Medication Error Reporting and Prevention Index, Categories E–I; E = tempo-
rary harm to the patient and required intervention, F = temporary harm to the patient and required initial or prolonged hospitalisation, G = permanent patient harm, H = intervention
required to sustain life, I = patient death [23]. †Preventability: probably preventable and preventable are regarded as “preventable” AEs.
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30 days” [29], indicating that, as a trigger, its PPV depends
heavily on how individual AEs are defined. As we adapted
our definition of the aforementioned trigger, the difference
in the PPV rate can be explained.
In fact, we calculated low to medium PPVs for most of our
laboratory values and medication triggers. This indicates
that, even where triggers are easily located in the EHR and
have values outside the reference range, the presence alone
of these conditions does not necessarily mean the patient
was harmed. On the one hand, a self-developed trigger
such as “sudden change in cognitive function”, which was
attributed a high PPV (86.2%), mostly reflected changes in
attention or cognition described in the nursing notes, often
indicated delirium – a condition strongly linked to patient
harm. On the other hand, the self-developed “phlebitis or
extravasation injury” trigger was detected in 82 cases, of
which only 8.5% were judged to involve AEs. The reason
for this low PPV is that if noticed early, an extravasation
injury itself is not harmful and removing the peripheral in-
travenous cannula reduces the risk of infection. Further re-
search is necessary to expand the list of triggers in the lo-
cal setting in order to detect the fullest possible spectrum
of AEs.
Adverse events
Our identification of 336 in-hospital AEs assigned to cat-
egories E–I will help to establish improvement strategies
[29, 31]. In order of incidence, the four most frequent in-
hospital AEs we discovered were infections (25.8%), neu-
rological reactions (22.9%), readmission within 30 days
(15.0%) and skin/tissue damage (10.0%).
Echoing the 2004 findings of the Swissnoso study, postop-
erative wound infections, pneumonia and urinary tract in-
fections [32] were the most often observed infections. The
Swissnoso study noted that the nosocomial infection rate
was highest in internal medicine. This is no surprise: in-
ternal medicine patients are often elderly, present multi-
ple morbidities (commonly including severe illnesses), and
frequently require invasive care measures (e.g., catheters,
surgical procedures). This combination of characteristics
leaves internal medicine patients particularly vulnerable to
nosocomial infection.
Inouye [33] found an overall incidence of delirium of
29–64% in general medicine and geriatric wards. This
helps explain the high rate of neurological reactions in our
study group.
In our study, we also found a remarkably high rate of skin/
tissue damage such as moisture-associated skin damage
(MASD) or the description of “reddish skin”. According to
Woo et al. [34], the increasing prevalence of MASD in the
aging population worldwide is placing significant burdens
both on patients and on their healthcare systems. To min-
imise the damage, healthcare staff will need to develop the
knowledge and skills to assess specific types of MASD and
apply appropriate interventions.
Our AE rate of 60% (95.7 AEs per 1000 patient days) was
more than three times higher than that found by Halfon
et al. (2017) in Swiss medical and surgical patients, using
a different methodological approach. That study reported
an incidence of 14.1% [11]. In six other general inpatient
studies, AEs ranged from 27–99 AEs per 1000 patient days
[3].
As found in other GTT studies [15, 35, 36], our study
group’s most frequent type of in-hospital AE was health-
care-associated infections. In general, we found that harm
categories E (43.5%) and F (42.6%), entailing temporary
harm to patients, were most common. This concurred with
the results of other studies, which found either harm level
E or F most prevalent [16, 35, 37, 38]. However, distin-
guishing between categories D and E can be very chal-
lenging, as it is sometimes unclear whether an intervention
was employed to prevent harm (category D) or to minimise
harm that had already occurred (category E).
Harm category H, defined as an intervention to sustain
life, was most common in response to healthcare-associat-
ed infections, and neurological and surgical AEs, and most
commonly accompanied transfers to an intensive care unit.
However, the inclusion of this transfer under harm catego-
ry H varies between studies [16, 38]. This may partly ex-
plain why our severe AE rates were higher than those mea-
sured in other studies [16, 38].
We found an in-hospital AE preventability of 29%, which
was low compared with the majority of the nine general in-
patient studies (range 14–71%, but with six of these clus-
tering between 50% and 65%) summarised in the 2016 sys-
tematic review of Hibbert et al. [10]. One reason for our
generally low preventability rate may be our high rate of
AEs: the extent to which an AE results from an error or
was the result of the natural disease process is often un-
clear. Therefore, preventability was assessed as rather low.
For example infections, which were among the most fre-
quent AEs, were considered to be preventable to a quar-
ter. The reasons for infections (e.g., poor hand hygiene, in-
accurate handling of catheters) are, however, often unclear
and cannot be determined to a specific day and time, which
makes it particularly difficult to judge the preventabili-
ty. In addition, preventability rates varied across our find-
ings: several types of AEs, such as diarrhoea and abnormal
blood values, have low preventability, whereas pressure ul-
cers have a preventability of almost 90%.
High interstudy variability regarding preventability has
been discussed previously [10]. The various scales in use
for measuring preventability certainly add to the chal-
lenges of accurate comparison. Diverse AE rates between
institutions, as well as the wide range of AE rates, may
result from the use of different triggers, AE definitions,
settings and methodologies [6, 10]. Our study used a de-
finition of AEs that included minor AEs such as fungal
infections, whereas other studies have been narrower, fo-
cussing on severe or preventable AEs [17]. Therefore, the
IHI [4] have suggested that AE rates be used to track
changes over time only within a single institution.
Interrater reliability
We found very high agreement between the primary re-
viewers regarding the presence of AEs (κ = 0.98), as well
as a high degree of consensus on the number of AEs be-
tween the two primary reviewers (κweighted = 0.96), and be-
tween the primary reviewers and the physician (κweighted =
0.98). In the systematic review of Hibbert et al. [10], in
which 22 studies measured interrater reliability there was
considerable variation in AE agreement both between the
primary reviewers (κ = 0.34–0.86) and between primary
and secondary reviewers (κ = 0.34–0.89). One plausible
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explanation for our reviewers’ high level of interrater relia-
bility is a combination of their shared training, the fact that
they were a consistent and experienced review team, their
use of a structured chart review protocol and their regular
participation in team discussions of the results aimed at re-
solving variations in triggers and AE identification. All of
these points have been emphasised by previous studies in
efforts to improve consistency and interrater reliability [4,
10, 39].
Clinical relevance
In Switzerland, approaches to measuring AE rates include
clinical surveillance of specific AE types (patient falls, sur-
gical site infections) [13], (voluntary) incident reporting
and, in some hospitals, morbidity and mortality confer-
ences [40, 41]. However, all of these approaches provide
only a partial view of AEs. This study has shown that the
GTT method is a detailed and comprehensive tool for the
detection of AEs.
However, the GTT cannot be applied without adaptations
to the local setting. Triggers must be adapted to local
events and operationalised to achieve a standardised ap-
proach. In addition, the definition of an AE and the gaug-
ing of its severity may give rise to arguments: it is unclear
how the level of harm is to be interpreted in each case. De-
spite the additional work necessary to apply GTT method-
ology, it provides a thorough system first for detecting
AEs, then for raising local awareness of them as a prelude
to implementing quality improvement strategies [29].
Limitations
Our study has several potential limitations that should be
taken into consideration:
1. Retrospective chart review, including via the GTT, de-
pends heavily on the quality of the EHR. For example,
where AEs occur but no corrective measures are docu-
mented, they cannot be identified.
2. The EHR facilitates the review process as all informa-
tion is provided in one place and not across different
archives. The EHR used provided seamless informa-
tion, even if the patient was transferred to another de-
partment of the hospital. However, we excluded two
modules (“emergency department” and “intensive
care”) from the GTT. Because of the lack of interop-
erability between the different EHR systems, we only
had limited data available in form of a summary. This
exclusion may have led to an underestimation of AE’s
in our study.
3. The small sample size of our retrospective chart review
and single-hospital patient sample may limit the gen-
eralisability of our findings.
4. We looked only at patient charts from the index hospi-
talisation. As noted above, tracing the origin of possi-
ble AEs and their harm would require investigation of
previous and subsequent patient charts.
5. Patients in internal medicine often suffer from multiple
chronic illnesses, leading to complex clinical situa-
tions. Even though we used a standardised GTT proto-
col, interpretation remains subjective, which may lead
to misclassification.
Future implications
Developing preventive strategies for the entire hospital
will require further investigation, including the application
of all six GTT modules to different wards in the study
hospital. At the same time, as suggested by a 2017 Swiss
chart review study [11], a national strategy will be neces-
sary to produce more reliable estimates of specific AE in-
cidence. As the chart review method is very resource-in-
tensive, despite the setting of triggers and a 20-minute time
limit for trigger detection, the possibility of automated trig-
ger/AE detection in the EHR [42, 43] – whether alone or in
combination with a chart review – is becoming increasing-
ly important. An additional advantage of automated trig-
ger detection would be the prospective detection of AEs.
In retrospective chart reviews, the patient record has been
closed and no further interventions can be made to limit
patient harm or to investigate factors contributing to AEs.
Prospective clinical surveillance [44] would provide a plat-
form to learn from mistakes. In such a situation, the imple-
mentation of interventions could reduce the likelihood of
AEs (or limit the harm they do) in future inpatients.
Conclusion
We identified 1371 positive triggers indicating 336 in-hos-
pital AEs in 240 medical patients in a university hospital
in Switzerland. Of the 336 AEs detected, almost a third
could have been prevented. Using the “care” and “med-
ication” modules, we found that the GTT offers a detailed
method of identifying AEs in medical inpatients. Our find-
ings provide evidence as to the nature of AEs and indi-
cate that patient safety could be improved by addressing
the most prevalent, severe and preventable AEs. An effi-
cient approach to identifying AEs and subsequently to im-
proving patient safety would be not only beneficial to the
patients, who could avoid unnecessary harm, but also cost
effective in terms of reduced hospital stays.
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